Tu Z; Wang C; Davis AK; Hu M; Zhao C; Xin M; Lu QR; Zheng Y. The chromatin remodeler CHD8 governs hematopoietic stem/progenitor survival by regulating ATM-mediated P53 protein stability. Blood. 2021; 138(3):221-233.

Zhang Z; Zhang F; Davis AK; Xin M; Walz G; Tian W; Zheng Y. CDC42 controlled apical-basal polarity regulates intestinal stem cell to transit amplifying cell fate transition via YAP-EGF-mTOR signaling. Cell Reports. 2022; 38(2):110009-.

Muto T; Guillamot M; Yeung J; Fang J; Bennett J; Nadorp B; Lasry A; Redondo LZ; Choi K; Gong Y. TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity. Cell Stem Cell. 2022; 29(2):298-314.e9.

Barreyro L; Sampson AM; Ishikawa C; Hueneman KM; Choi K; Pujato MA; Chutipongtanate S; Wyder M; Haffey WD; O'Brien E. Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia. Science Translational Medicine. 2022; 14(635):eabb7695-.

Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis. eLife. 2022; 11.